CLYYF OTC
Celyad Oncology S.A.
1W: +0.0%
1M: +0.0%
3M: +12.0%
YTD: +86.7%
1Y: -31.7%
3Y: -99.4%
$0.28
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
📊 Key Metrics
TTM$0M
Revenue
+102.9% YoY
$-5M
Net Income
+88.0% YoY
$-11M
Free Cash Flow
+75.8% YoY
30417.0%
Gross Margin
-49016.9%
Op. Margin
64360.6%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE-114.9%
ROA-48.8%
ROIC-1433.2%
Valuation
P/E2.7
P/B8.0
EV/EBITDA0.0
Leverage
Debt/Equity0.00
Current Ratio1.92
Interest Cov.-70.9x
Quality Scores
Piotroski F4/9
Altman Z—
Beneish M15.32